Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth

2023 . Keller, Magdalena | Rohlf, Katharina | Glotzbach, Annika | Leonhardt, Gregor | Lüke, Simon | Derksen, Katharina | Demirci, Özlem | Göçener, Defne | AlWahsh, Mohammad | Lambert, Jörg | Lindskog, Cecilia | Schmidt, Marcus | Brenner, Walburgis | Baumann, Matthias | Zent, Eldar | Zischinsky, Mia-Lisa | Hellwig, Birte | Madjar, Katrin | Rahnenführer, Jörg | Overbeck, Nina | Reinders, Jörg | Cadenas, Cristina | Hengstler, Jan | Edlund, Karolina | Marchan, Rosemarie